HTEA ( DrugBank: - )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 57 | Idiopathic dilated cardiomyopathy | 1 |
57. Idiopathic dilated cardiomyopathy
Clinical trials : 12 / Drugs : 25 - (DrugBank : 12) / Drug target genes : 9 - Drug target pathways : 34
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02292043 (ClinicalTrials.gov) | May 2013 | 31/10/2014 | Effects of HTEA ON Heart Failure Secondary to Idiopathic Dilated Cardiomyopathy or Post-myocardial Infarction | Effects of HTEA ON Heart Failure Secondary to Idiopathic Dilated Cardiomyopathy or Post-myocardial Infarction | Congestive Heart Failure | Drug: HTEA | Harbin Medical University | NULL | Recruiting | 20 Years | 80 Years | Both | 60 | N/A | China |